- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03418298
Prehabilitation in Patients With Esophageal or Gastric Cancers
May 19, 2020 updated by: Cliniques universitaires Saint-Luc- Université Catholique de Louvain
Objectives: The primary objective of this study is to assess the feasibility of a internet-based preoperative exercise program in patients with esophageal or gastric cancers.
Secondary objectives are to evaluate the effects of this preoperative program on functional capacity, anxiety and depression, quality of life and fatigue Methods: This feasibility study will be conduct at University Hospital Saint-Luc in Brussels.
Twenty patients with esophageal or gastric cancers will participate in internet-based program 3 sessions per week.
Each session will combine aerobic and resistance training.
Moreover, inspiratory muscle strengthening (IMT) will be performed daily.
The researcher will conduct weekly telephone calls to educate and motivate subjects.
Assessments will be performed at baseline, one day before surgery, 1 month and 3 months after surgery.
The following parameters will be measured: functional capacity, quality of life, fatigue, anxiety and depression.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
30
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Woluwé-Saint-Lambert
-
Brussels, Woluwé-Saint-Lambert, Belgium, 1200
- Cliniques Universitaires Saint-luc
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Diagnosis of esophageal cancer or gastric cancer requiring surgery
- More than 18 years
- Able to read, write and understand French or English
- Time before surgery > 2 weeks
Exclusion Criteria:
- Surgical emergency
- Cognitive or neuropsychiatric diseases
- Neuromuscular or orthopedic disorders limiting exercises
- Cardiopulmonary disease contraindicating exercises
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Prehabilitation group
Subjects will carry out a preoperative internet-based program including aerobic and resistance training three sessions per week
|
Subjects will performed an internet-based exercise program before surgery
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Retention rate
Time Frame: At study completion (3 months after surgery)
|
Proportion of patients who complete the tele-prehabilitation and all assessments
|
At study completion (3 months after surgery)
|
|
Attendance
Time Frame: At study completion (3 months after surgery)
|
(Number of completed sessions/Number of planned sessions) x 100
|
At study completion (3 months after surgery)
|
|
Program satisfaction
Time Frame: At study completion (3 months after surgery)
|
Program satisfaction will be evaluated by a questionnaire including items about internet program
|
At study completion (3 months after surgery)
|
|
Percentage of patients who experienced one or more adverse events
Time Frame: At study completion (3 months after surgery)
|
Adverse events will be evaluated by listing adverse events that occur (e.g.
fall, injury or exercise-related symptom)
|
At study completion (3 months after surgery)
|
|
Recruitment rate
Time Frame: At study completion (3 months after surgery)
|
ratio of the number of the recruited patients to the number of eligible patients
|
At study completion (3 months after surgery)
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in functional capacity
Time Frame: Baseline, one day before surgery, 1 and 3 months after surgery
|
Functional capacity will be assessed by 6-minute walk test
|
Baseline, one day before surgery, 1 and 3 months after surgery
|
|
Change in quality of life
Time Frame: Baseline, one day before surgery, 1 and 3 months after surgery
|
Quality of life using the Functional Assessment of Cancer Therapy-General (FACT-G).
Each item is rated from 0 (not at all) to 4 (very much) with a total score ranging from 0 to 102.
The higher the score, the better the QoL.
|
Baseline, one day before surgery, 1 and 3 months after surgery
|
|
Change in fatigue
Time Frame: Baseline, one day before surgery, 1 and 3 months after surgery
|
Fatigue using the Functional Assessment of Cancer Therapy-Fatigue questionnaire (FACIT-F).
Each item is rated from 0 (not at all) to 4 (very much) with a total score ranging from 0 to 52.
The higher the score, the lower the fatigue.
|
Baseline, one day before surgery, 1 and 3 months after surgery
|
|
Change in anxiety and depression
Time Frame: Baseline, one day before surgery, 1 and 3 months after surgery
|
Anxiety and depression using the Hospital Anxiety and Depression Scale (HADS).
Scores for each subscale (depression and anxiety) are summed-up and range from 0 to 21.
Values from 0-7 indicate normal levels, 8-10 are border values, and values from 11-21 are considered to be pathological
|
Baseline, one day before surgery, 1 and 3 months after surgery
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
February 27, 2018
Primary Completion (Actual)
November 1, 2019
Study Completion (Actual)
December 15, 2019
Study Registration Dates
First Submitted
January 10, 2018
First Submitted That Met QC Criteria
January 25, 2018
First Posted (Actual)
February 1, 2018
Study Record Updates
Last Update Posted (Actual)
May 21, 2020
Last Update Submitted That Met QC Criteria
May 19, 2020
Last Verified
May 1, 2020
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- e-move
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
UNDECIDED
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Gastric Cancer
-
City of Hope Medical CenterCompletedGastric Cancer | Gastric Adenocarcinoma | Gastric Cancer Stage IV | Gastric Neoplasm | Gastric Cancer Metastatic to Lung | Gastric Cancer Stage | Gastric Cancer Metastatic to Liver | Gastric Cancer Stage III | Gastric Cancer Stage II | Gastric Lesion | Gastric Cancer in Situ | Gastric Cancer Stage IIIB | Gastric... and other conditionsUnited States, Japan
-
City of Hope Medical CenterNational Cancer Institute (NCI)Active, not recruitingGastric Adenocarcinoma | Clinical Stage III Gastric Cancer AJCC v8 | Clinical Stage 0 Gastric Cancer AJCC v8 | Clinical Stage I Gastric Cancer AJCC v8 | Clinical Stage II Gastric Cancer AJCC v8 | Clinical Stage IIA Gastric Cancer AJCC v8 | Clinical Stage IIB Gastric Cancer AJCC v8 | Pathologic Stage... and other conditionsUnited States
-
City of Hope Medical CenterCompletedAdenocarcinoma of the Gastroesophageal Junction | Stage IV Gastric Cancer | Recurrent Gastric Cancer | Diffuse Adenocarcinoma of the Stomach | Intestinal Adenocarcinoma of the Stomach | Mixed Adenocarcinoma of the Stomach | Stage IIIA Gastric Cancer | Stage IIIB Gastric Cancer | Stage IIIC Gastric Cancer and other conditionsUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)Active, not recruitingGastric Adenocarcinoma | Clinical Stage III Gastric Cancer AJCC v8 | Clinical Stage I Gastric Cancer AJCC v8 | Clinical Stage IIA Gastric Cancer AJCC v8 | Clinical Stage IVA Gastric Cancer AJCC v8 | Pathologic Stage IB Gastric Cancer AJCC v8 | Pathologic Stage II Gastric Cancer AJCC v8 | Pathologic... and other conditionsUnited States
-
National Cancer Institute (NCI)CompletedGastric Adenocarcinoma | Stage IV Gastric Cancer | Stage II Gastric Cancer | Stage III Gastric CancerUnited States
-
Ukrainian Society of Clinical OncologyRecruitingGastric Cancer | Gastrectomy for Gastric Cancer | Gastric Cancer Stage III | Gastric Cancer Stage IIUkraine
-
Lin LiuRecruitingGastric Carcinoma | Gastric Neoplasm | Gastric Cancer Adenocarcinoma Metastatic | Gastric (cardia, Body) CancerChina
-
Rutgers, The State University of New JerseyNational Cancer Institute (NCI)Active, not recruitingGastric Adenocarcinoma | Epstein-Barr Virus Positive | Mismatch Repair Protein Deficiency | Stage IB Gastric Cancer AJCC v7 | Stage II Gastric Cancer AJCC v7 | Stage IIA Gastric Cancer AJCC v7 | Stage IIB Gastric Cancer AJCC v7 | Stage III Gastric Cancer AJCC v7 | Stage IIIA Gastric Cancer AJCC v7 | Stage... and other conditionsUnited States
-
Mayo ClinicNational Cancer Institute (NCI)CompletedGastroesophageal Junction Adenocarcinoma | Gastric Cardia Adenocarcinoma | Stage IB Gastric Cancer AJCC v7 | Stage II Gastric Cancer AJCC v7 | Stage IIA Gastric Cancer AJCC v7 | Stage IIB Gastric Cancer AJCC v7 | Stage IIIA Gastric Cancer AJCC v7 | Stage IIIB Gastric Cancer AJCC v7United States
-
Ukrainian Society of Clinical OncologyRecruitingStomach Cancer | Gastric Cancer | Chemotherapy | Gastric Adenocarcinoma | Gastrectomy | Gastrointestinal Cancer | Gastroesophageal Junction Adenocarcinoma | Advanced Gastric Adenocarcinoma | GastroEsophageal Cancer | Stomach Neoplasm | Gastric Neoplasm | Advanced Gastric Carcinoma | Gastrectomy for Gastric Cancer | Advanced Gastroesophageal Junction Adenocarcinoma and other conditionsLithuania, Ukraine
Clinical Trials on Prehabilitation group
-
University of Health Sciences Balikesir Hospital...CompletedFatigue Syndrome, Chronic | Prehabilitation | Breast Cancer-Related Arm Lymphedema | Quality of Life ImpairmentTurkey (Türkiye)
-
University of British ColumbiaNot yet recruitingAdolescent Idiopathic Scoliosis
-
Riphah International UniversityCompleted
-
Riphah International UniversityCompleted
-
University of JaénHospital Clinico Universitario San CecilioRecruitingKnee Osteoarthritis | Hip Osteoarthritis | Prehabilitation | Physical Therapy ModalitiesSpain
-
Stanford UniversityCompletedSurgery | Thoracic Diseases | Gastrointestinal Disease | Preoperative Care | Gynecologic Disease | Immune System and Related Disorders | Urological DiseaseUnited States
-
Dana-Farber Cancer InstituteRecruitingMultiple Myeloma | Stem Cell Transplant ComplicationsUnited States
-
Istituto Ortopedico GaleazziMinistry of Health, ItalyRecruiting
-
Peking Union Medical College HospitalRecruitingLung Cancer | Recovery | Lobectomy | Perioperative | Prehabilitation | ThoracoschisisChina
-
Mount Sinai Hospital, CanadaUniversity Health Network, TorontoUnknownPhysical Activity | Surgery | Gastrointestinal Cancer | PrehabilitationCanada